⌘K

Login Start Free

Home/Filings/4/0000950170-24-103955

4//SEC Filing

Warren Lucinda 4

Accession 0000950170-24-103955

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:00 PM ET

Size

5.3 KB

Accession

0000950170-24-103955

Insider Transaction Report

Form 4

Period: 2024-09-03

Cue Biopharma, Inc.CUE

CHIEF BUSINESS OFFICER

Transactions

Award
Stock Option (right to buy)
2024-09-03+350,000→ 350,000 total
Exercise: $0.66Exp: 2034-09-02→ Common Stock (350,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable in four equal semi-annual installments beginning on March 3, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0002035620

Filing Metadata

Form type: 4
Filed: Sep 4, 8:00 PM ET
Accepted: Sep 5, 4:00 PM ET
Size: 5.3 KB

View on SEC.gov